| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/30/2001 | CA2396960A1 Novel use of phenylheteroalkylamine derivatives |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1127883A2 Oxamides as IMPDH inhibitors |
| 08/29/2001 | EP1127882A1 Tetrazole compounds as thyroid receptor ligands |
| 08/29/2001 | EP1127577A2 Ligand for the c-kit receptor and methods of use thereof |
| 08/29/2001 | EP1127355A1 Products and methods for brachytherapy |
| 08/29/2001 | EP1127151A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 08/29/2001 | EP1127133A2 Polypeptide mediating cell permeability |
| 08/29/2001 | EP1127129A1 Myosin heavy chain homolog |
| 08/29/2001 | EP1127123A2 Cell surface glycoproteins |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127110A1 Modified exosomes and uses |
| 08/29/2001 | EP1127109A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 08/29/2001 | EP1127107A1 Methods for the production of tcr gamma delta t cells |
| 08/29/2001 | EP1127075A2 A method of treating tumors using fas-induced apoptosis |
| 08/29/2001 | EP1127070A2 $i(IKAROS) ISOFORMS AND MUTANTS |
| 08/29/2001 | EP1127068A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 08/29/2001 | EP1127058A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 08/29/2001 | EP1127054A1 Novel inhibitors of impdh enzyme |
| 08/29/2001 | EP1127052A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 08/29/2001 | EP1127051A2 Tricyclic pyrazole derivatives |
| 08/29/2001 | EP1126884A2 Radiodense compositions |
| 08/29/2001 | EP1126878A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 08/29/2001 | EP1126877A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 08/29/2001 | EP1126876A2 Adjuvant systems and vaccines |
| 08/29/2001 | EP1126872A1 CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT |
| 08/29/2001 | EP1126871A2 Combination therapy with vip antagonist |
| 08/29/2001 | EP1126869A2 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
| 08/29/2001 | EP1126865A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 08/29/2001 | EP1126856A1 Compounds and their therapeutic use with diabetic complications |
| 08/29/2001 | EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 08/29/2001 | EP1126845A2 New use of immunosuppressants for mmp-mediated diseases |
| 08/29/2001 | EP1126843A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 08/29/2001 | EP1126842A2 Inhibition of the formation of vascular hyperpermeability |
| 08/29/2001 | EP1126839A1 Substituted phenethylsulfones and method of reducing tnf alpha levels |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP1126832A2 Conductance of improperly folded proteins through the secretory pathway |
| 08/29/2001 | EP1126828A1 Oral administration of adenosine analogs |
| 08/29/2001 | EP1126782A1 Method for improved imaging and photodynamic therapy |
| 08/29/2001 | EP0968168B1 Aromatic tetracyclic compounds of the retinoid type, method for preparing and use |
| 08/29/2001 | EP0914043A4 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 08/29/2001 | EP0904299B1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides |
| 08/29/2001 | EP0889877B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 08/29/2001 | EP0851866B1 Therapeutic compounds |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | EP0618925B1 Antisense oligonucleotides |
| 08/29/2001 | CN1310716A Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 08/29/2001 | CN1310713A Substituted quinazoline derivatives |
| 08/29/2001 | CN1310708A Substituted phenylamidines with antithrombotic action |
| 08/29/2001 | CN1310705A Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 08/29/2001 | CN1310618A Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 08/29/2001 | CN1310610A Pharmaceutical composition in particular for preventing and treating mucositis induced by radiotherapy or chemotherapy |
| 08/29/2001 | CN1310179A Oxamide being as IMPDH inhibitor |
| 08/29/2001 | CN1310025A Therapeutical compound and its application |
| 08/29/2001 | CN1310022A Method of making medicine from extracting metabolic product of staphylococcus aureus and thallus protein |
| 08/29/2001 | CN1310015A Anticancer drug compounding process |
| 08/29/2001 | CN1309999A Yiyuansan powder as one orally taken medicine for treating liver cancer and its preparation |
| 08/29/2001 | CN1309978A Xianggu mushroom injection and oral liquid as hepatitis virus and cancer resisting medicine |
| 08/29/2001 | CN1309970A Application of uridine phosphorylase inhibitor and composition containing the same |
| 08/29/2001 | CN1309964A Carbazole-alkoloid cell cycle inhibitor, cell death inducer and their preparation |
| 08/29/2001 | CN1070198C Isolated nucleic acid molecule of coded tumor rejection antigen precursor DAGE and its application |
| 08/29/2001 | CN1070176C 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals |
| 08/28/2001 | US6281365 (Gem-heterocyclodimethanamine-n,n′)platinum complexes |
| 08/28/2001 | US6281363 Antiinflammatory agents; antiarthritic agents; autoimmune disorders |
| 08/28/2001 | US6281356 Substituted pyrroles |
| 08/28/2001 | US6281354 Analogs of duocarmycin and cc-1065 |
| 08/28/2001 | US6281223 Coadministering x-ray radiation and orally dosed 9-nitrocamptothecin |
| 08/28/2001 | US6281205 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 08/28/2001 | US6281204 19-nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, and the intermediates of this process, their use as medicaments and compositions |
| 08/28/2001 | US6281202 Pharmaceutical compositions for treatment of EGF receptor associated cancers |
| 08/28/2001 | US6281198 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro-[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one compounds |
| 08/28/2001 | US6281197 Inhibiting the export of a leaderless protein such as fgf from a cell by contacting the cell with a cardiac glycoside |
| 08/28/2001 | US6281196 Isolated from western pacific marine sponge agelas sp. |
| 08/28/2001 | US6281194 E.g., (s)-(1-((4-benzyloxy-benzyl)-(((1-phenyl-cyclobutylmethyl)-car bamoyl)-methyl)-carbamoyl)-2-(1h-imidazol-4-yl)-ethyl)-carbami c acid benzyl ester |
| 08/28/2001 | US6281175 Medical emulsion for lubrication and delivery of drugs |
| 08/28/2001 | US6280991 Engineered cytotoxic ribonclease |
| 08/28/2001 | US6280978 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 08/28/2001 | US6280975 Adjusted interleukin polypeptide for use in the treatment of myelomas, tumors, osteoporosis and autoimmune diseases |
| 08/28/2001 | US6280953 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/28/2001 | US6280774 Extraction of bile from animals, stimulating monocytes and macrophages and modulating tumor necrosis factor production |
| 08/28/2001 | US6280742 Methods and materials for the treatment of prostatic carcinoma |
| 08/28/2001 | US6280739 Method of inhibiting angiogenesis using secreted proteins |
| 08/28/2001 | US6280732 Administering intracerebrally al-1 immunoadhesin comprising mature al-1 polypeptide having specified amino acid sequence in amount effective to activate autophosphorylation of rek7 |
| 08/28/2001 | US6280706 Chelating agents |
| 08/28/2001 | CA2079902C Antibody conjugates for treatment of neoplastic disease |
| 08/28/2001 | CA2015996C Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals |
| 08/24/2001 | CA2337588A1 Oxamides as impdh inhibitors |
| 08/23/2001 | WO2001061356A1 Her-2 binding antagonists |
| 08/23/2001 | WO2001061055A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001061010A2 Gtpase activating proteins |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001060998A2 Small oligonucleotides with anti-tumor activity |
| 08/23/2001 | WO2001060996A1 Method of controlling telomere length |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060979A1 Pancreatic islet cell growth factors |